Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma
- 23 July 2009
- journal article
- case report
- Published by Elsevier in Pathology - Research and Practice
- Vol. 206 (1) , 9-13
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The effect of methotrexate and anti–tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 PERSON‐YEARS of observationArthritis & Rheumatism, 2007
- Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese casesPathology - Research and Practice, 2006
- Reactivation of Latent Epstein-Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated LymphomasJNCI: Journal of the National Cancer Institute, 2004
- Angioimmunoblastic T cell lymphoma is derived from mature T‐helper cells with varying expression and loss of detectable CD4International Journal of Cancer, 2002
- Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10Blood, 2002
- Risk of malignancy among patients with rheumatic conditionsInternational Journal of Cancer, 2000
- Lymphoma in Patients with Rheumatoid ArthritisDrug Safety, 1999
- Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.Journal of Clinical Oncology, 1996
- Spectrum of Histopathologic PatternsAmerican Journal of Surgical Pathology, 1995
- Long‐Term Prospective Study of the Use of Methotrexate in the Treatment of Rheumatoid ArthritisArthritis & Rheumatism, 1992